Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1

Interventions

Carboplatin 33 Pemetrexed 25 Cisplatin 23 Paclitaxel 20 Radiotherapy 16 Docetaxel 16 Gemcitabine 15 durvalumab 14 Radiosurgery 14 pembrolizumab 13 Nivolumab 13 Erlotinib Hydrochloride 10 Taxes 8 atezolizumab 7 Magnetic Resonance Spectroscopy 7 Drug Therapy 6 Cyclophosphamide 6 Bevacizumab 6 Platinum 5 Gefitinib 5 130-nm albumin-bound paclitaxel 5 Etoposide 4 Biopsy 4 Albumin-Bound Paclitaxel 4 1,2-diaminocyclohexaneplatinum II citrate 4 spartalizumab 3 sotorasib 3 poly ICLC 3 capmatinib 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma, Non-Small-Cell Lung × figitumumab × Clear all

NCT00907504 2014-06-17

ADVIGO1017

Pfizer

Phase 3 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡